Implementing a Recombinant Cascade Reagent for Bacterial Endotoxin Testing

[Article Title]

In the dynamic landscape of pharmaceutical manufacturing and quality assurance, the development of testing methodologies remains a cornerstone of ensuring product safety and compliance with regulatory standards. Among these critical testing methods, Bacterial Endotoxin Testing (BET) is a vital quality control measure. Adopting recombinant technologies for BET presents a significant stride toward sustainable and more environmentally friendly testing practices while maintaining the efficiency and reliability of traditional Limulus Amebocyte Lysate (LAL) reagents. This article will overview the developments within recombinant technologies, review peer-reviewed publications on the comparability of PyroSmart NextGen® to LAL reagents, practical implementation of recombinant cascade reagents (rCR) for BET in the laboratory, and navigate the complexities of regulatory implications and industry standards. Download now to learn more.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.